New strategies for the in vivo regulation of metalloprotease gene expression in osteoarthritis chondrocytes by inflammatory mediators

Samankaltaisia teoksia

• Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis
  Tekijä: Boileau, C, et al.
  Julkaistu: (2004)
• PD‐0200347, an α(2)δ ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKCα dependent effect
  Tekijä: Boileau, C, et al.
  Julkaistu: (2006)
• PPARγ ligands inhibit catabolic and inflammatory responses in articular joint cells
  Tekijä: Fahmi, H, et al.
  Julkaistu: (2003)
• Galectin-3 in osteoarthritis: from a protective to a destructive role
  Tekijä: Boileau, C, et al.
  Julkaistu: (2004)
• Differential gene expression and regulation of the bone morphogenic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts
  Tekijä: Tardif, G, et al.
  Julkaistu: (2004)